HCC progression was driven by ZNF217 after mobilizing LSD1 at the CDH1/E-cadherin promoter, leading to in situ depletion of H3K4me2 and decreased CDH1/E-cadherin transcription. The gene discussed is ZNF217; the disease is hepatocellular carcinoma.